Skip to main content
. Author manuscript; available in PMC: 2009 Dec 21.
Published in final edited form as: Am J Transplant. 2008 Jun 28;8(8):1662–1672. doi: 10.1111/j.1600-6143.2008.02303.x

Table 1.

Concurrent pathology
Pathology on biopsy Banff arterial inflammation >v0 Presence of alloantibodies TG> cg1 Positive C4d PTC Banff acute> suspicious
TG> cg1 0.600 <0.001 <0.001 0.012
Fibrosis ≥50% 0.820 0.001 <0.001 <0.001 0.77
Banff acute > suspicious <0.001 0.110 0.100 0.060
Banff arterial inflammation >v0 0.970 0.910 0.990 <0.001
Positive C4d PTC 0.150 <0.001 <0.001 0.15
Presence of alloantibodies 0.970 <0.001 <0.001 0.22
Banff infiltrate >i1 0.230 0.280 0.380 0.670 <0.001
Banff glomerular inflammation >g1 0.001 0.001 <0.001 0.001 0.002
N > 150
Later pathology
Pathology on biopsy Banff acute > suspicious Positive C4d PTC Chronic arteriopathy TG > cg1 Fibrosis ≥50%
TG > cg1 >0.05 <0.001 <0.001 <0.001
Fibrosis ≥50% >0.05 0.050 0.150 0.040
Banff acute > suspicious 0.110 0.630 0.120 0.67
Banff arterial inflammation >v0 <0.001 0.600 <0.001 0.730 0.74
Positive C4d PTC >0.05 <0.001 <0.001 <0.001
Presence of alloantibodies 0.150 <0.001 <0.001 <0.001 <0.001
Banff infiltrate >i1 < 0.001 0.720 0.680 0.360 0.36
Banff glomerular inflammation >g1 >0.05 <0.001 <0.001 <0.001 0.001
N > 150; for CAA (autopsies) >47